MyMD Pharmaceuticals® Announces Issuance of U.S. Patent for Synthetic Cannabinoid Compounds for Treating Neuroinflammatory and Neurodegenerative Diseases

August 10, 2021

MyMD Pharmaceuticals® Announces Issuance of U.S. Patent for Synthetic Cannabinoid Compounds for Treating Neuroinflammatory and Neurodegenerative Diseases

View More

Back to All News

Subscribe to receive MyMD announcements
  • This field is for validation purposes and should be left unchanged.